EUVIMEDEUVIMED entdecken
Crossref

Incidence and risk factors for neoplasia in inflammatory bowel disease

Joana Lemos Garcia iD, Isadora Rosa, João Pereira da Silva, Joana Moleiro, Isabel Claro

Asia-Pacific Journal of Clinical Oncology · 2024

DOI: 10.1111/ajco.13908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2024. Verfasst von Joana Lemos Garcia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Neoplasms. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inflammatory Bowel Disease (IBD) patients may have an increased risk of neoplasia. The aim was to evaluate the incidence of malignant neoplasia in IBD patients, associated risk factors and therapy adjustments.

Methods

Unicentric retrospective cohort study. All patients followed for IBD in a tertiary portuguese hospital and oncological centre during 2015–2020 were included.

Results

318 patients were included female 55.0%, age at diagnosis = 37.24(±15,28), Crohn's disease 52.5%, Primary Sclerosing Cholangitis n = 7, family history of cancer n = 12, previous diagnosis of neoplasia n = 23(7.2%). 42 cancers were diagnosed in 35 patients (11.0%) ‐ median of 12.0(IQR = 7.5‐21.0) years after IBD diagnosis. Most affected organs were the skin (n = 15 in 11 patients; melanoma = 1), colon/rectum (n = 8 in 6 patients), prostate (n = 4), breast (n = 3) and anal canal (n = 2). In those with non‐melanoma skin cancer, 6 were under active treatment with azathioprine and 2 had stopped it for more than two years. In the univariate analysis, the occurrence of neoplasia was positively associated with tobacco exposure (p = 0.022), age at IBD diagnosis (p = 0.021), and negatively with infliximab exposure (p = 0.046). In 9 cases, cancer treatment was different because of the IBD, while IBD treatment was changed in 9 patients. In those affected by cancer, in the univariate analysis, its cure/remission was negatively associated with tobacco exposure (p = 0.004) and positively with salicylates use (p = 0.007).

Conclusion

In IBD patients, cancer mostly affected the skin and the lower digestive system. As in the general population, tobacco exposure was a risk factor for the development of neoplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesNeoplasmsHumansFemaleMaleRisk FactorsRetrospective StudiesIncidenceAdultMiddle AgedPortugal

Stichwörter der Autor:innen

cancercrohn's diseaseinflammatory bowel diseaseneoplasiaulcerative colitis

Autor:innen und Institutionen

  • Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal.

ORCID-Profile: Joana Lemos Garcia

Zitieren

APA

Garcia, J. L., Rosa, I., da Silva, J. P., Moleiro, J., & Claro, I. (2024). Incidence and risk factors for neoplasia in inflammatory bowel disease. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.13908

Vancouver

Garcia JL, Rosa I, da Silva JP, Moleiro J, Claro I. Incidence and risk factors for neoplasia in inflammatory bowel disease. Asia-Pacific Journal of Clinical Oncology. 2024. doi:10.1111/ajco.13908

BibTeX
@article{Garcia2024,
  author = {Garcia, Joana Lemos and Rosa, Isadora and da Silva, João Pereira and Moleiro, Joana and Claro, Isabel},
  title = {Incidence and risk factors for neoplasia in inflammatory bowel disease},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1111/ajco.13908}
}
Kostenlos starten →